reports
Assemblée Générale Mixte du 24 avril 2026
Assemblée Générale Mixte du 24 avril 2026 ➢Approbation d’un dividende de 7,20 euros par action, en augmentation de + 2,9 % ; ➢ Nominations de M. Pablo Isla, Mme Anna Lenz et Mme Christel Bories en qualité d’administrateurs ; ➢ Renouvellement des mandats d’administrateurs de MM. Jean-Paul Agon et Patrice Caine. À la suite du renouvellement de son mandat d’administrateur par l’Assemblée, Monsieur Jean-Paul Agon est confirmé dans ses fonctions de Président du Conseil d’Administration ; ➢ Interventions de M. Nicolas Hieronimus, Directeur Général, sur la double performance du Groupe, fina...
Annual General Meeting of 24 April 2026
Annual General Meeting of 24 April 2026 ➢ Approval of a dividend of €7.20 per share, an increase of +2.9%; ➢ Appointment of Mr. Pablo Isla, Ms. Anna Lenz, and Ms. Christel Bories as Directors; ➢ Renewal of the directorships of Mr. Jean-Paul Agon and Mr. Patrice Caine. Following the renewal of his directorship by the Meeting, Mr. Jean-Paul Agon was confirmed as Chairman of the Board of Directors; ➢ Presentations by Mr. Nicolas Hieronimus, CEO, on the Group's dual financial and non-financial performance and strategy for the coming years, and by Mr. Samuel du Retail, General Manager AI – Da...
Bankinter S.A.: 2 directors
A director at Bankinter S.A. bought 3,512 shares at 14.160EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU app...
Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses Recommendation based on the HERCULES phase 3 study which demonstrated that brain-penetrant Cenrifki (tolebrutinib) significantly delayed the onset of disability progression in non-relapsing SPMS Paris, April 24, 2026. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CH...
Communiqué de presse : Cenrifki de Sanofi (tolebrutinib) recommandé pa...
Communiqué de presse : Cenrifki de Sanofi (tolebrutinib) recommandé par le Comité des médicaments à usage humain (CMUH) pour être approuvé par l’UE pour le traitement de la sclérose en plaques secondairement progressive sans poussées Cenrifki de Sanofi (tolebrutinib) recommandé par le Comité des médicaments à usage humain (CMUH) pour être approuvé par l’UE pour le traitement de la sclérose en plaques secondairement progressive sans poussées Recommandation basée sur HERCULES, une étude de phase 3 qui a démontré que Cenrifki (tolebrutinib) pénétrant dans le cerveau retardait significativemen...
- Maissa Keskes
- Stephane Houri
AC ACCOR SA
HEIA HEINEKEN NV
SGO COMPAGNIE DE SAINT-GOBAIN SA
EDEN EDENRED SA
IPN IPSEN SA
DG VINCI SA
VOLV B VOLVO AB CLASS B
SK SEB SA
KNIN KUEHNE & NAGEL INTERNATIONAL AG
SRT3 SARTORIUS AG PREF
NOKIA NOKIA OYJ
NESN NESTLE S.A.
ENI ENI S.P.A.
SCHP SCHINDLER HOLDING AG PREF
BOL BOLLORE SA
BKT BANKINTER SA
DIM SARTORIUS STEDIM BIOTECH SA
COLO B COLOPLAST A/S CLASS B
SPIE SPIE SA
SAP SAP SE
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
ULA UNIBAIL-RODAMCO-WESTFIELD SE STAPLED SECS CONS OF 1 SH UNIBAIL RODAMCO + 1 SH WFD UNIB ROD
ADYEN ADYEN NV
ENR SIEMENS ENERGY AG
DSY DASSAULT SYSTEMES SA
SGSN SGS SA
GALD GALDERMA GROUP AG
- Maissa Keskes
- Stephane Houri
AC ACCOR SA
HEIA HEINEKEN NV
SGO COMPAGNIE DE SAINT-GOBAIN SA
EDEN EDENRED SA
IPN IPSEN SA
DG VINCI SA
VOLV B VOLVO AB CLASS B
SK SEB SA
KNIN KUEHNE & NAGEL INTERNATIONAL AG
SRT3 SARTORIUS AG PREF
NOKIA NOKIA OYJ
NESN NESTLE S.A.
ENI ENI S.P.A.
SCHP SCHINDLER HOLDING AG PREF
BOL BOLLORE SA
BKT BANKINTER SA
DIM SARTORIUS STEDIM BIOTECH SA
COLO B COLOPLAST A/S CLASS B
SPIE SPIE SA
SAP SAP SE
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
ULA UNIBAIL-RODAMCO-WESTFIELD SE STAPLED SECS CONS OF 1 SH UNIBAIL RODAMCO + 1 SH WFD UNIB ROD
ADYEN ADYEN NV
ENR SIEMENS ENERGY AG
DSY DASSAULT SYSTEMES SA
SGSN SGS SA
GALD GALDERMA GROUP AG
- Maissa Keskes
- Stephane Houri
- Maissa Keskes
- Stephane Houri
- Benoit Valleaux
- Steven Gould
- Benoit Valleaux
- Steven Gould
- ABGSC Telecom Equipment Research
- Simon Granath
- Alvaro del Pozo
- Maissa Keskes
- Stephane Houri
HEIA HEINEKEN NV
GET GETLINK SE
EDEN EDENRED SA
IPN IPSEN SA
CA CARREFOUR SA
BVI BUREAU VERITAS SA
BN DANONE SA
BNP BNP PARIBAS SA CLASS A
RNO RENAULT SA
ORA ORANGE SA
CBK COMMERZBANK AG
GFC GECINA SA
ABB ABB LTD.
SAND SANDVIK AB
RXL REXEL SA
LSEG LONDON STOCK EXCHANGE GROUP PLC
SRT3 SARTORIUS AG PREF
NOKIA NOKIA OYJ
EL ESSILORLUXOTTICA SA
NESN NESTLE S.A.
OR L'OREAL SA
SCHP SCHINDLER HOLDING AG PREF
SAN SANOFI
SAF SAFRAN S.A.
MOCORP METSO OUTOTEC OYJ
DIM SARTORIUS STEDIM BIOTECH SA
BIM BIOMERIEUX SA
BG BAWAG GROUP AG
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
ERF EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
DSY DASSAULT SYSTEMES SA
ML COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
P911 DR. ING. H.C. F. PORSCHE AKTIENGESELLSCHAFT
SGSN SGS SA
GALD GALDERMA GROUP AG
ROG ROCHE HOLDING AG
- Maissa Keskes
- Stephane Houri
HEIA HEINEKEN NV
GET GETLINK SE
EDEN EDENRED SA
IPN IPSEN SA
CA CARREFOUR SA
BVI BUREAU VERITAS SA
BN DANONE SA
BNP BNP PARIBAS SA CLASS A
RNO RENAULT SA
ORA ORANGE SA
CBK COMMERZBANK AG
GFC GECINA SA
ABB ABB LTD.
SAND SANDVIK AB
RXL REXEL SA
LSEG LONDON STOCK EXCHANGE GROUP PLC
SRT3 SARTORIUS AG PREF
NOKIA NOKIA OYJ
EL ESSILORLUXOTTICA SA
NESN NESTLE S.A.
OR L'OREAL SA
SCHP SCHINDLER HOLDING AG PREF
SAN SANOFI
SAF SAFRAN S.A.
MOCORP METSO OUTOTEC OYJ
DIM SARTORIUS STEDIM BIOTECH SA
BIM BIOMERIEUX SA
BG BAWAG GROUP AG
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
ERF EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
DSY DASSAULT SYSTEMES SA
ML COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
P911 DR. ING. H.C. F. PORSCHE AKTIENGESELLSCHAFT
SGSN SGS SA
GALD GALDERMA GROUP AG
ROG ROCHE HOLDING AG
- Pierre Tegner
- Pierre Tegner
- Florent Cespedes
- Martial Descoutures
- Florent Cespedes
- Martial Descoutures
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.